For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Goodfellow Gems #121
Wednesday 25 March 2020, 01:30 AM

“Systolic blood pressure of 140mmHg treated to 120mmHg: No increase in concern about falling”
In an extra analysis of the SPRINT trial, where hypertensive patients were randomised to a systolic blood pressure treatment target of 140mmHg or 120m
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
References: 1. https://bit.ly/2wNzEeO (J Am Geriatr Soc 2019; 28 November online). 2. https://bit.ly/37VEIux (N Engl J Med 2015;373:2103–16).